共 149 条
[1]
Barquera S(2015)Global overview of the epidemiology of atherosclerotic cardiovascular disease Arch Med Res 46 328-338
[2]
Pedroza-Tobias A(2015)Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013 Lancet 385 117-171
[3]
Medina C(2014)Targeting activated platelets and fibrinolysis: hitting two birds with one stone Circ Res 114 1070-1073
[4]
Hernandez-Barrera L(2016)Executive summary: heart disease and stroke statistics--2016 update: a report from the American Heart Association Circulation 133 447-454
[5]
Bibbins-Domingo K(2013)Rapid health transition in China, 1990-2010: findings from the Global Burden of Disease Study 2010 Lancet (London, England) 381 1987-2015
[6]
Lozano R(2019)Optimal antiplatelet therapy in moderate to severe asymptomatic and symptomatic carotid stenosis: a comprehensive review of the literature Eur J Vasc Endovasc Surg 57 199-211
[7]
Reheman A(2013)Managing the residual cardiovascular disease risk associated with HDL-cholesterol and triglycerides in statin-treated patients: a clinical update Nutr Metab Cardiovasc Dis 23 799-807
[8]
Xu X(2017)Protease-activated receptor 1 inhibitors: novel antiplatelet drugs in prevention of atherothrombosis Am J Ther 24 e730-e736
[9]
Reddy EC(2017)Is anti-platelet therapy always necessary in asymptomatic 30-40% carotid stenosis? J Cardiovasc Med (Hagerstown) 18 e112-e116
[10]
Ni H(2012)Statin and aspirin therapy for the prevention of cardiovascular events in patients with type 2 diabetes mellitus Clin Cardiol 35 722-729